Another study on circulating tumor cells (CTCs) in lung cancer suggested that homogeneous mesenchymal phenotype was observed in ALK-rearranged CTCs, which indicated EMT may be triggered by ALK tyrosine kinase activation and then promotion of tumor cell migratory properties [37]. This evidence concerns the gene ALK and lung cancer.